miRoncol Health
Back to news
April 3, 2025

Selected to Present at Venture Summit West

From the miRoncol archive: This historical update may contain promotional language or research findings that do not describe the current service. Retrospective research results do not establish prospective screening performance, and references to scientific prizes do not imply evaluation or endorsement of miRoncol or miCheckup. Do not rely on this archive for healthcare decisions; use the current product information and discuss screening decisions with a healthcare professional.

miRoncol Health is pleased to share its attendance and presentation at Venture Summit West, held April 2–3, 2025, in Mountain View, CA. This highly anticipated premier event served as a crucial gathering point, connecting top-tier investors, innovative startups, and influential industry leaders for two intensive days of unparalleled networking opportunities, insightful discussions, and a showcase of groundbreaking innovation.

Our CEO, Victoria Xu, was excited to participate in this dynamic forum, where miRoncol Health had the opportunity to share our vision and advancements in early cancer detection. We were keen to engage with potential partners and investors who shared our commitment to transforming healthcare and making a significant impact on global health. This summit provided an invaluable platform to highlight our progress, discuss future strategies, and forge collaborations that will accelerate our mission to bring accessible and effective cancer screening solutions to the forefront.